RYAN | Ticker Profile - Titan Protect

RYAN

Ryan Specialty Holdings, Inc.

Financial Services · Insurance - Specialty · NYQ

$32.56

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$8.6B

Total market value of the company

Trailing P/E

39.89

Expensive — high growth expected

Forward P/E

13.97

Based on estimated future earnings — lower means cheaper

Rev Growth

+15.8%

Year-over-year revenue change

Profit Margin

3.5%

How much profit the company keeps from each dollar of revenue

ROE

22.8%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$39.00

+20% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 17 analysts covering this stock

About Ryan Specialty Holdings, Inc.

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, individual, and government sectors. The company was founded in 2010 and is headquartered in Chicago, Illinois.

https://www.ryanspecialty.com

Country: United States Employees: 6,144 Industry: Insurance - Specialty

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

-0.559

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0566

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.374

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-22.8%

Historical annualised return based on price data

Max Drawdown

-60.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.68

Less volatile than the market — more defensive

52W High

$72.50

55% below the year high

52W Low

$29.28

11% above the year low

Avg Volume

2,257,093

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.5

Days it would take all short sellers to cover — higher means more crowded

Short % Float

11.8%

Elevated short interest — bears are positioned against this

Div Yield

159.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$0.82

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

307.01

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.02

Adequate but worth monitoring

Quick Ratio

0.14

Like current ratio but excludes inventory — stricter test

Gross Margin

41.8%

Revenue left after cost of goods — higher means pricing power

Operating Margin

17.4%

Profit from core operations before interest and tax

Free Cash Flow

$595M

Positive — the business generates more cash than it spends

Revenue (TTM)

$3.1B

Total revenue over the last 12 months

Net Income

$109M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$76.00

Target Median

$39.00

Target Low

$31.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go